Corporate Restructuring

GSP Crop Science Approves Scheme of Amalgamation and Demerger to Consolidate Wholly Owned Subsidiaries

NSE

gspcrop

BSE

544733

GSP Crop Science Limited has approved a composite Scheme of Arrangement involving the amalgamation of Rajdhani Petrochemicals Private Limited (RPPL) and the demerger of the manufacturing undertaking of GSP Intermediates Private Limited (GIPL) into GSP Crop Science. The restructuring aims to simplify the group structure, consolidate assets and liabilities, improve operational efficiency, and unlock long-term synergies. The proposal remains subject to statutory and regulatory approvals.

PRICE-SENSITIVE TRIGGER

Event:

Amalgamation of Rajdhani Petrochemicals Private Limited with GSP Crop Science Limited.
Demerger of the manufacturing undertaking of GSP Intermediates Private Limited into GSP Crop Science Limited.

Type: Corporate Restructuring

Impact: Positive

Immediate Effect: The Board has approved the restructuring proposal. The scheme will become effective only after obtaining all necessary statutory, regulatory and judicial approvals. No change occurs immediately in the company’s shareholding structure.

Key Metrics:

Transferor Company (RPPL) Total Income: ₹124.51 crore (FY26)
Transferor Company Net Worth: ₹64.54 crore
Transferee Company Total Income: ₹1,627.61 crore (FY26)
Transferee Company Net Worth: ₹734.47 crore
Demerged Manufacturing Undertaking Turnover (FY26): ₹28.26 crore
Segment Performance: Manufacturing undertaking of GIPL generated FY26 turnover of ₹28.26 crore.

Highlight:

Corporate Restructuring Objective: Consolidation of wholly owned subsidiaries without issuing new equity shares or paying cash consideration.

What Happened ?

GSP Crop Science’s Board approved a composite Scheme of Arrangement under Sections 230–232 of the Companies Act, 2013.

The proposal includes:

Amalgamation of wholly owned subsidiary Rajdhani Petrochemicals Private Limited into GSP Crop Science.
Demerger of the manufacturing undertaking of wholly owned subsidiary GSP Intermediates Private Limited into GSP Crop Science.

The appointed date for the scheme is 1 April 2026. Upon effectiveness, all assets and liabilities of RPPL and the demerged undertaking of GIPL will be transferred to GSP Crop Science at their carrying values. Since both subsidiaries are wholly owned, no new equity shares will be issued and no cash consideration will be involved.

Key Details

Key Features of the Approved Scheme:

Board approved a composite amalgamation and demerger scheme.
Appointed date fixed as 1 April 2026.
Entire assets and liabilities of RPPL and GIPL’s manufacturing undertaking will vest in GSP Crop Science.
Both RPPL and GIPL are wholly owned subsidiaries of GSP Crop Science.
Existing investment held by GSP in RPPL and GIPL will stand cancelled upon effectiveness.
No fresh equity shares will be issued.
No cash consideration is payable.
Shareholding pattern of GSP Crop Science will remain unchanged.
Listing status of GSP Crop Science remains unaffected since it is already listed.
Primary objectives include operational consolidation, simplification of legal structure, cost optimisation, improved capital utilisation, stronger balance sheet integration and enhanced management efficiencies.

Note:

The Scheme is subject to approvals from shareholders, creditors, regulatory authorities and the applicable judicial forums before becoming effective.

Risk Analysis

Summary:

The proposed restructuring is strategically positive but remains contingent upon completion of the statutory approval process. Until the Scheme becomes effective, the operational structure remains unchanged.

Key Risks:

Completion depends on regulatory, shareholder and judicial approvals.
Delay in approvals could postpone expected operational synergies.
Integration benefits will materialize only after implementation.
Since no financial guidance has been provided, immediate earnings impact cannot be quantified.

Worst Case:

Failure to obtain the required approvals would prevent implementation of the Scheme, leaving the current corporate structure unchanged.

Risk Level: Medium

Company Commentary

The restructuring is intended to streamline the corporate structure and consolidate operations.
Management expects better utilization of combined resources, assets, reserves and workforce.
The Scheme aims to reduce duplicate legal and administrative compliances.
Operational efficiencies, lower compliance costs and improved capital allocation are expected.
The restructuring is designed to support long-term sustainable growth and enhance stakeholder value.
No dilution of existing shareholders will occur as no new shares are proposed to be issued.

Official Exchange Filing: GSP Crop Science Limited

Support our work by sharing